Guizhong L. Zhang

Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Co-activating the intrinsic FcRγ/TLR4 signaling axis enhances the antitumor activity of NKG2D CAR-macrophages against prostate cancer.

Co-activating the intrinsic FcRγ/TLR4 signaling axis enhances the antitumor activity of NKG2D CAR-macrophages against prostate cancer.

Journal: Biochemical and biophysical research communications

Published: February 11, 2026

TIPE2 gene knockdown in mice attenuates experimental colitis by diminishing inflammatory cell infiltration.

TIPE2 gene knockdown in mice attenuates experimental colitis by diminishing inflammatory cell infiltration.

Journal: Molecular therapy. Nucleic acids

Published: October 09, 2025

TIPE2 regulates LRRC33-Mediated TGF-β1 activation in MDSCs to restrict lung cancer PD-1 blockade immunotherapy.

TIPE2 regulates LRRC33-Mediated TGF-β1 activation in MDSCs to restrict lung cancer PD-1 blockade immunotherapy.

Journal: Biochemical and biophysical research communications

Published: September 16, 2025

CD86 costimulation enhances the antitumor activity of NKG2D CAR-Macrophages and synergizes with Anti-PD-L1 therapy to suppress prostate cancer progression.

CD86 costimulation enhances the antitumor activity of NKG2D CAR-Macrophages and synergizes with Anti-PD-L1 therapy to suppress prostate cancer progression.

Journal: Cell communication and signaling : CCS

Published: June 26, 2025

DR5 CAR-NK cells demonstrate superior scalability and potent antitumor activity with favorable safety.

DR5 CAR-NK cells demonstrate superior scalability and potent antitumor activity with favorable safety.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 23, 2025

Lentinan enhances CAR-T cell potency in solid tumors by optimizing T cell differentiation.

Lentinan enhances CAR-T cell potency in solid tumors by optimizing T cell differentiation.

Journal: Frontiers in immunology

Published: April 03, 2025

Flagellin engineering enhances CAR-T cell function by reshaping tumor microenvironment in solid tumors.

Flagellin engineering enhances CAR-T cell function by reshaping tumor microenvironment in solid tumors.

Journal: Journal for immunotherapy of cancer

Published: March 21, 2025

NY-ESO-1 facilitates anoikis resistance and tumor metastasis by hijacking deubiquitinase OTUB1 to stabilize PP1α.

NY-ESO-1 facilitates anoikis resistance and tumor metastasis by hijacking deubiquitinase OTUB1 to stabilize PP1α.

Journal: Cell death & disease

Published: January 25, 2025

TIPE2 deficiency amplifies inflammation and immune dysregulation in MASH through modulating hepatic lipid metabolism and immune cell function.

TIPE2 deficiency amplifies inflammation and immune dysregulation in MASH through modulating hepatic lipid metabolism and immune cell function.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: December 24, 2024

CD28 is superior to 4-1BB costimulation in generating CAR-NK cells for tumor immunotherapy.

CD28 is superior to 4-1BB costimulation in generating CAR-NK cells for tumor immunotherapy.

Journal: Experimental hematology & oncology

Published: October 30, 2024

Sodium valproate enhances efficacy of NKG2D CAR-T cells against glioblastoma.

Sodium valproate enhances efficacy of NKG2D CAR-T cells against glioblastoma.

Journal: Frontiers in immunology

Published: October 30, 2024

Multifaceted roles of DLG3/SAP102 in neurophysiology, neurological disorders and tumorigenesis.

Multifaceted roles of DLG3/SAP102 in neurophysiology, neurological disorders and tumorigenesis.

Journal: Neuroscience

Published: September 06, 2024

Showing 1-12 of 38

Last Updated: 09/26/2026